Messenger RNA (mRNA) technology has made global headlines recently due to its prominent role in combatting the COVID-19 virus. This relatively new breakthrough in vaccinology has established itself as a promising alternative to traditional vaccination methods because it is safe for immunocompromised patients, is cost-effective, and can be quickly manufactured.
Today more than 535 million COVID-19 mRNA vaccines have been administered, and based on an independent analysis by the Food and Drug Administration, mRNA vaccines have demonstrated as high as 95% efficacy.
To build on this momentum of success, leading biotech companies are rapidly exploring opportunities to leverage mRNA technology with the goal of developing novel vaccinations and immunotherapy treatments that protect against a variety of harmful illnesses.
Learn more about mRNA vaccine technology in Atlantic Health Partner’s latest blog.
About Atlantic Health Partners
Atlantic Health Partners is the nation’s leading vaccine buying group and works with many Ohio chapter members. Atlantic offers you the most favorable prices for a wide range of vaccines from Merck, Sanofi Pasteur, Pfizer, and Seqirus.
For more information, or to see how your practice can benefit from Atlantic’s free program, please contact Cindy Berenson or Jeff Winokur via email or by calling 800.741.2044.